Resistance and Progression Mechanisms in Prostate Cancer

Alvaro Aytés Meneses

PRINCIPAL INVESTIGATORS
  • Mireia Olivan Riera
CLINICAL RESEARCHERS
  • Natalia Picola Brau
  • Jose Francisco Suarez Novo
  • Maria Pané Foix
  • Manuel Castells Esteve
POSTDOCTORAL RESEARCHERS
  • Lidia Franco Luzon
  • Rana El Bizri
  • Ana Sofia Semiao Correia Da Rocha
PREDOCTORAL RESEARCHERS
  • Sonia Farran Matas
  • Adrian Martinez Tébar
SCIENTIFIC SUPPORT
  • Xieng Chen Wang
  • Nadia García Lozano
Cancer
Oncobell

Scientific production

7

PAPERS

Average IF: 6,464

2

LED PAPERS

Average IF: 6,387

2 PUBLICATIONS IN FIRST DECILE

3 PUBLICATIONS IN FIRST QUARTILE

4 PUBLICATIONS IN FIRST QUARTILE

Selected publications

  • Suárez JF, Zamora V, Garin O, Gutiérrez C, Pont À, Pardo Y, Goñi A, Mariño A, Hervás A, Herruzo I, Cabrera P, Sancho G, Ponce de León J, Macías V, Guedea F, Vigués F, Castells M, Ferrer M, Multicentric Spanish Group of Clinically Localized Prostate C. Mortality and biochemical recurrence after surgery, brachytherapy, or external radiotherapy for localized prostate cancer: a 10-year follow-up cohort study. Sci Rep. 2022;12(1):12589-12589. doi:10.1038/s41598-022-16395-w.
  • Pané Foix M, Fernandez Calvo D, Condom Mundó I, Suarez Novo JF, Merino Serra E, Garcia Benett JR, Gomà Gàllego M, Yun Viladomat S, Vigués Julià F, Vidal Bel I. Clinical relevance of amyloid in prostate samples: a report on 40 patients. Histopathology. 2022;doi:10.1111/his.14717.
  • Rodríguez Barrueco,R;Latorre,J;Devis Jáuregui,L; Lluch,A; Bonifaci,N; Llobet,FJ; Olivan, M et al, A microRNA Cluster Controls Fat Cell Differentiation and Adipose Tissue Expansion By Regulating SNCG., Adv. Sci., 2022;9(4):doi:10.1002/advs.202104759
  • Peremiquel Trillas P, Paytubi S, Pelegrina B, Frias Gomez J, Carmona Á, Martínez JM, de Francisco J, Benavente Y, Barahona M, Briansó F, Canet Hermida J, Caño V, Vidal A, Zanca A, Baixeras N, Rodríguez A, Fernández Gonzalez S, Dueñas N, Càrdenas L, Aytés Á, Bianchi I, Pavón MÀ, Reventós J, Capellà G, Gómez D, Diaz M, Ponce J, Brunet J, Matias Guiu X, Bosch FX, de Sanjosé S, Alemany L, Pineda M, Marin F, Costas L. An Integrated Approach for the Early Detection of Endometrial and Ovarian Cancers (Screenwide Study): Rationale, Study Design and Pilot Study. J. Pers. Med. 2022;12(7):doi:10.3390/jpm12071074.
  • Plata Bello A, Apatov SE, Benfante NE, Rivero Belenchón I, Picola Brau N, Mercader Barrull C, Jenjitranant P, Vickers AJ, Fine SW, Touijer KA. Prevalence of High-Risk Prostate Cancer Metastasis to Cloquet’s Ilioinguinal Lymph Node. J Urol. 2022;207(6):1222-1226. doi:10.1097/JU.0000000000002439.

Research highlights

PROJECTS

3 Granted competitive projects
10 Ongoing competitive projects

4 Ongoing clinical trials

PUBLISHED WORKS

1 Thesis

NETWORKS

AGAUR – SGR
MINECO – Red de Excelencia

Selected projects

  • 18INT004. Mechanisms ant therapeutic targeting of NSD2 in advanced prostate cancer. DEPARTMENT OF DEFENSE. Budget: 352372,94. 2018-2023. PI: Aytes Meneses, Alvaro.
  • USA21005. Dissecting the role of cancer cell chromatin remodeling on the landscape of tumor immune microenvironment. DEPARTMENT OF DEFENSE. Budget: 465431,26. 2022-2025. PI: Aytes Meneses, Alvaro.
  • AEC21002. Dissecting EZH2-SWI/SNF antagonism to target cell plasticity in therapy resistant prostate cancer. Asociación Española Contra el Cáncer (AECC). Budget: 299363,42. 2021-2024. PI: Aytes Meneses, Alvaro.
  • 20CEE005. RegARcis: Role of the SWI/SNF complex in the Androgen Receptor cistrome regulation. COMISSIÓ EUROPEA. Budget: 160932,48. 2020-2022. PI: EL BIZRI, RANA.
  • 18PNJ004. IDENTIFYING SYNERGISTIC INTERACTIONS TO ANDROGEN RECEPTOR BLOCKADE WITH APALUTAMIDE IN GENETICALLY MODIFIED MOUSE MODELS OF CASTRATION RESISTANT PROSTATE CANCER: FOCUS ON BTK/BMX INHIBITORS AND EPIGENETIC DRUGS. Jansen . Budget: 161700. 2018-2023. PI: Aytes, Alvaro.